Towards a Safe, Effective Vaccine for Rift Valley Fever Virus
- 1 November 2010
- journal article
- Published by Taylor & Francis in Future Virology
- Vol. 5 (6) , 675-678
Abstract
Evaluation of: Bhardwaj N, Heise MT, Ross TM: Vaccination with DNA plasmids expressing Gn coupled to C3d or a-virus replicons expressing Gn protects mice against Rift Valley fever virus. PLoS Negl. Trop. Dis. 4(6), E725 (2010). Rift Valley fever virus (RVFV) is an important animal and human threat and leads to long-standing morbidity and mortality in susceptible hosts. Since no therapies currently exist to treat Rift Valley fever, it remains a public and animal health priority to develop safe, effective RVFV vaccines (whether for animals, humans, or both) that provide long-term protective immunity. In the evaluated article, Bhardwaj and colleagues describe the creation and testing of two successful vaccine strategies against RVFV, a DNA plasmid vaccine expressing Gn coupled to C3d, and an alpha-virus replicon vaccine expressing Gn protein. Both vaccines elicited strong neutralizing antibody responses, prevented morbidity and mortality in RVFV-challenged mice, and enabled protection of naive mice via passi...Keywords
This publication has 13 references indexed in Scilit:
- Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice against Rift Valley Fever VirusPLOS Neglected Tropical Diseases, 2010
- Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever VirusVirology, 2009
- An alphavirus replicon-derived candidate vaccine against Rift Valley fever virusEpidemiology and Infection, 2009
- Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructsVirology Journal, 2009
- Rift Valley Fever Virus Lacking the NSs and NSm Genes Is Highly Attenuated, Confers Protective Immunity from Virulent Virus Challenge, and Allows for Differential Identification of Infected and Vaccinated AnimalsJournal of Virology, 2008
- Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteinsVirology, 2007
- NSm and 78-Kilodalton Proteins of Rift Valley Fever Virus Are Nonessential for Viral Replication in Cell CultureJournal of Virology, 2006
- Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virusVaccine, 2006
- An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98Emerging Infectious Diseases, 2002
- Viral Hemorrhagic Fever Hazards for Travelers in AfricaClinical Infectious Diseases, 2001